Merging of PC in the DBU

Quote

anonymous

Guest
What exactly is going to happen in Q2 when PC1 & PC2 have to explain why they can supposedly see HCPs that PC3 cannot? Neuro reps are taking note of the calls their overlaps are putting in on no see providers. You all worried about call plans when you have to explain that a practice sees you and not a single other drug rep?
 












anonymous said:
What exactly is going to happen in Q2 when PC1 & PC2 have to explain why they can supposedly see HCPs that PC3 cannot? Neuro reps are taking note of the calls their overlaps are putting in on no see providers. You all worried about call plans when you have to explain that a practice sees you and not a single other drug rep?
Click to expand...
Lol! Let me guess, new Neuro rep. You do realize who you are working for, right? Check the box to meet the metrics they are applying to every territory regardless of the pandemic. You will understand as soon as you start to get pressure from your manager. No excuses. Find a way.
 






Answering to the above poster. There are reps on the industry that are able to see docs where other reps are not. They may have been around longer, already know the doc or just better at getting into an office. This is the problem with all these new interns that Lilly has hired. They don’t have the intelligence on how to see hard to see physicians. Just because you can’t see them doesn’t mean I can’t.
 






Top Bottom
Back
Quote